Structures by: Vangala V. R.
Total: 91
C14H11ClNO2,C7H11N2
C14H11ClNO2,C7H11N2
IUCrJ (2020) 7, 2 173-183
a=7.9299(5)Å b=9.3219(4)Å c=13.5862(9)Å
α=87.768(4)° β=76.928(5)° γ=76.025(5)°
C14H11ClNO2,C7H11N2,H2O
C14H11ClNO2,C7H11N2,H2O
IUCrJ (2020) 7, 2 173-183
a=7.7631(6)Å b=8.0250(6)Å c=16.2297(12)Å
α=101.784(6)° β=98.374(6)° γ=90.687(6)°
C14H12ClNO2,C14H11ClNO2,C7H11N2
C14H12ClNO2,C14H11ClNO2,C7H11N2
IUCrJ (2020) 7, 2 173-183
a=10.8864(7)Å b=12.2705(7)Å c=13.7811(10)Å
α=106.966(6)° β=105.782(6)° γ=103.324(5)°
2(C7H6Cl0.5N0.5O),2(C1.5H3.5N0.5O0.5)
2(C7H6Cl0.5N0.5O),2(C1.5H3.5N0.5O0.5)
IUCrJ (2020) 7, 2 173-183
a=10.4803(6)Å b=11.8423(9)Å c=13.3309(8)Å
α=94.335(5)° β=95.883(5)° γ=102.871(6)°
C15H14NO2,C7H11N2
C15H14NO2,C7H11N2
IUCrJ (2020) 7, 2 173-183
a=7.7575(8)Å b=9.4727(7)Å c=13.3076(13)Å
α=87.515(7)° β=78.596(8)° γ=74.174(8)°
C14H12ClNO2
C14H12ClNO2
IUCrJ (2020) 7, 2 173-183
a=6.7049(3)Å b=7.2778(3)Å c=14.1630(6)Å
α=77.167(4)° β=79.908(3)° γ=65.487(4)°
C15H14NO2,C15H15NO2,C7H11N2
C15H14NO2,C15H15NO2,C7H11N2
IUCrJ (2020) 7, 2 173-183
a=10.7678(8)Å b=11.9673(10)Å c=13.7860(11)Å
α=106.152(7)° β=105.842(7)° γ=103.490(7)°
C15H14NO2,H2O,C7H11N2
C15H14NO2,H2O,C7H11N2
IUCrJ (2020) 7, 2 173-183
a=7.7248(3)Å b=8.0592(3)Å c=16.2531(7)Å
α=101.711(4)° β=98.743(4)° γ=90.160(3)°
Benzaldehyde pentafluoromethylidenehydrazone
C14H7F5N2
Chemical Communications (2002) 12 1304
a=5.9053(2)Å b=7.4709(3)Å c=14.3540(5)Å
α=102.927(2)° β=92.143(2)° γ=91.222(2)°
Bis(Pentafluorophenylmethylidenehydrazone)
C14H2F10N2
Chemical Communications (2002) 12 1304
a=6.65700(10)Å b=7.9005(2)Å c=13.1424(3)Å
α=90.00° β=103.6800(10)° γ=90.00°
1:1 Complex of Benzalazine : bis(Pentafluorophenylmethylidenehydrazone)
C14H2F10N2.C14H12N2
Chemical Communications (2002) 12 1304
a=7.2820(2)Å b=7.9073(2)Å c=11.9305(4)Å
α=93.052(2)° β=93.590(2)° γ=113.3100(10)°
4-aminothiphenol
C6H7NS
Chemical Communications (2004) 22 2526-2527
a=7.2305(12)Å b=5.8513(10)Å c=7.7552(13)Å
α=90.00° β=107.364(3)° γ=90.00°
Acesulfame Form I
C4H5NO4S
Chemical Communications (2010) 46, 20 3562-3564
a=7.4940(15)Å b=11.784(2)Å c=15.238(3)Å
α=90.00° β=101.36(3)° γ=90.00°
Acesulfame Form II
C4H5NO4S
Chemical Communications (2010) 46, 20 3562-3564
a=6.3310(2)Å b=7.4720(3)Å c=7.7150(3)Å
α=62.5460(15)° β=73.1710(18)° γ=77.874(2)°
1:1 Cocrystal of nitrofurantoin and 4-hydroxybenzoic acid
C8H6N4O5,C7H6O3
CrystEngComm (2011) 13, 3 759
a=10.298(2)Å b=6.4096(13)Å c=24.680(7)Å
α=90.00° β=108.08(3)° γ=90.00°
Nitrofurantoin-pyridine(1:1)
C13H11N5O5
CrystEngComm (2013) 15, 5 878
a=8.3012(17)Å b=12.940(3)Å c=14.208(3)Å
α=111.01(3)° β=96.22(3)° γ=91.11(3)°
1:1:1 solvate of nitrofurantoin, 3-picoline and water
C8H6N4O5,C6H7N,H2O
CrystEngComm (2013) 15, 5 878
a=15.268(6)Å b=6.4161(19)Å c=8.461(3)Å
α=90.00° β=105.286(5)° γ=90.00°
Nitrofurantoin-3-picoline(1:1)
C14H13N5O5
CrystEngComm (2013) 15, 5 878
a=6.1489(12)Å b=7.4328(15)Å c=16.446(3)Å
α=85.35(3)° β=85.97(3)° γ=83.67(3)°
1:1 nitrofurantoin and 4-picoline
C8H6N4O5,C6H7N
CrystEngComm (2013) 15, 5 878
a=14.840(3)Å b=8.0152(16)Å c=12.951(3)Å
α=90.00° β=91.12(3)° γ=90.00°
1:1:1 cocrystal of nitrofurantoin, 2-pyridone and acetonitrile
C8H6N4O5,C5H5NO,C2H3N
CrystEngComm (2013) 15, 5 878
a=8.1736(16)Å b=9.3544(19)Å c=11.894(2)Å
α=103.46(3)° β=109.31(3)° γ=90.14(3)°
1:1 salt of nitrofurantoin and 4-dimethylaminopyridine
C15H16N6O5
CrystEngComm (2013) 15, 5 878
a=8.616(4)Å b=26.655(11)Å c=7.029(3)Å
α=90.00° β=100.722(9)° γ=90.00°
1:1:1 cocrystal of nitrofurantoin, 2-pyridone and acetonitrile
C8H6N4O5,C7H8N2O,C2H3N
CrystEngComm (2013) 15, 5 878
a=7.2712(15)Å b=18.918(4)Å c=15.451(4)Å
α=90.00° β=117.41(2)° γ=90.00°
Nitrofurantoin and 2-Picoline(1:1)
C8H6N4O5,C6H7N
CrystEngComm (2013) 15, 5 878
a=7.0324(14)Å b=22.647(4)Å c=10.031(4)Å
α=90.00° β=112.38(2)° γ=90.00°
C11H20B10O2
C11H20B10O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 13 5014-5020
a=10.050(2)Å b=7.5783(15)Å c=22.381(6)Å
α=90.00° β=110.40(3)° γ=90.00°
Benzene-1,3,5-tricarboxylic acid tris-(4-iodo-phenyl) ester
C27H15I3O6
Chemical communications (Cambridge, England) (2008) 39 4726-4728
a=29.911(3)Å b=5.6474(6)Å c=31.534(4)Å
α=90.00° β=103.112(5)° γ=90.00°
Benzene-1,3,5-tricarboxylic acid tris(4-iodophenyl) ester chloroform solvate
C27H15I3O6,3(CHCl3)
Chemical communications (Cambridge, England) (2008) 39 4726-4728
a=16.3917(3)Å b=16.3917(3)Å c=24.8007(12)Å
α=90.00° β=90.00° γ=120.00°
Benzene-1,3,5-tricarboxylic acid tris(4-iodophenyl) ester pyridine solvate
(C27H15O6I3),3(C5H5N1)
Chemical communications (Cambridge, England) (2008) 39 4726-4728
a=16.5590(18)Å b=16.5590(18)Å c=8.4752(9)Å
α=90.00° β=90.00° γ=120.00°
Benzene-1,3,5-tricarboxylic acid tris(4-iodophenyl) ester benzene solvate
C27H15O6I3,1.5(C6H6)
Chemical communications (Cambridge, England) (2008) 39 4726-4728
a=16.5473(17)Å b=16.5473(17)Å c=8.4380(9)Å
α=90.00° β=90.00° γ=120.00°
1,3,5-tris(4-Bromobenzoyl)benzene
C27H15Br3O3
Chemical Communications (2006)
a=8.7341(9)Å b=11.0843(11)Å c=12.6991(13)Å
α=95.413(5)° β=98.622(5)° γ=107.017(5)°
1,3,5-tris(4-Iodobenzoyl)benzene
C27H15I3O3
Chemical Communications (2006)
a=7.3649(7)Å b=13.8815(13)Å c=24.580(2)Å
α=90.00° β=92.966(5)° γ=90.00°
1,3,5-tris(4-Fluorobenzoyl)benzene
C27H15F3O3
Chemical Communications (2006)
a=22.757(2)Å b=8.7286(9)Å c=10.5930(11)Å
α=90.00° β=101.174(5)° γ=90.00°
(1,3,5-tris(4-Bromobenzoyl)benzene).(1,3,5-tris(4- Chlorobenzoyl)benzene)
(C27H15O3Br3)0.552,(C27H15O3Cl3)0.448
Chemical Communications (2006)
a=8.6566(9)Å b=11.0606(11)Å c=12.6155(13)Å
α=95.743(5)° β=98.372(5)° γ=106.709(5)°
1:1 complex of bis(4-aminophenyl)disulfide and 4-aminothiophenol
C12H12N2S2,C6H7N1S1
Acta Crystallographica Section C (2002) 58, 10 o635-o636
a=15.210(3)Å b=6.0099(11)Å c=19.683(4)Å
α=90.00° β=96.814(3)° γ=90.00°
Nitrofurantoin methanol monosolvate
C8H6N4O5,CH4O
Acta Crystallographica Section E (2011) 67, 3 o550-o551
a=6.4084(13)Å b=6.5941(13)Å c=26.705(5)Å
α=90.00° β=91.70(3)° γ=90.00°
2A3MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=21.6090(7)Å b=7.4822(2)Å c=8.2703(3)Å
α=90.00° β=90.00° γ=90.00°
2A4MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=7.5058(15)Å b=7.7076(15)Å c=22.691(5)Å
α=90.00° β=90.00° γ=90.00°
2A5MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=8.7860(5)Å b=9.9708(5)Å c=7.8700(4)Å
α=90.00° β=113.966(2)° γ=90.00°
3A2MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=6.6782(6)Å b=8.1351(7)Å c=11.9301(10)Å
α=90.00° β=101.661(2)° γ=90.00°
3A5MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=6.02390(10)Å b=15.2605(3)Å c=7.4566(2)Å
α=90.00° β=107.5570(10)° γ=90.00°
5A2MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=5.5990(10)Å b=7.971(2)Å c=7.700(2)Å
α=90.00° β=110.020(10)° γ=90.00°
4A2MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=4.48940(10)Å b=10.4759(3)Å c=14.3300(4)Å
α=90.00° β=93.1740(10)° γ=90.00°
4A3MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=4.6823(2)Å b=11.5155(5)Å c=12.0314(5)Å
α=90.00° β=96.884(2)° γ=90.00°
8A2HNAP
C10H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=12.415(2)Å b=4.1719(7)Å c=15.511(3)Å
α=90.00° β=108.804(3)° γ=90.00°
Trans-4-Amino-cyclohexanol
C6H13NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=5.259(2)Å b=11.954(5)Å c=11.730(4)Å
α=90.00° β=95.486(8)° γ=90.00°
2A6MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=8.0069(2)Å b=8.0094(2)Å c=20.3862(5)Å
α=83.8860(10)° β=84.7190(10)° γ=89.1200(10)°
3A4MP
C7H9NO
Journal of the American Chemical Society (2005) 127, 10545-10559
a=7.5998(2)Å b=18.3860(5)Å c=9.9035(3)Å
α=90.00° β=110.1720(10)° γ=90.00°
4-(4-aminobenzyl)phenol
C13H13NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=5.9180(12)Å b=19.213(4)Å c=9.6510(19)Å
α=90.00° β=101.25(3)° γ=90.00°
4-(3-aminophenyl)phenol
C12H11NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=19.2352(8)Å b=6.0039(3)Å c=8.1627(4)Å
α=90.00° β=90.00° γ=90.00°
4-(4-aminobenzyl)phenol
C13H13NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=5.9820(3)Å b=19.3670(9)Å c=9.7390(4)Å
α=90.00° β=100.860(2)° γ=90.00°
4-(4-aminophenethyl)phenol
C14H15NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=13.682(3)Å b=5.2619(11)Å c=8.1916(16)Å
α=90.00° β=107.28(3)° γ=90.00°
4-[3-(4-aminophenyl)propyl]phenol
C15H17NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=23.9370(7)Å b=6.2160(2)Å c=8.3970(3)Å
α=90.00° β=90.00° γ=90.00°
4-[4-(4-aminophenyl)butyl]phenol
C16H19NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=15.7888(16)Å b=5.2088(6)Å c=8.3399(8)Å
α=90.00° β=100.912(5)° γ=90.00°
4-(4-aminobenzylsulfamyl)phenol
C13H13NOS
Journal of the American Chemical Society (2003) 125, 14495-14509
a=13.844(3)Å b=5.1626(10)Å c=8.2485(16)Å
α=90.00° β=107.22(3)° γ=90.00°
4-(4-aminophenylsulfamylmethyl)phenol
C13H13NOS
Journal of the American Chemical Society (2003) 125, 14495-14509
a=13.7422(12)Å b=5.1725(4)Å c=8.3055(7)Å
α=90.00° β=105.548(4)° γ=90.00°
4-(4-aminophenyldisulfamyl)phenol
C12H11NOS2
Journal of the American Chemical Society (2003) 125, 14495-14509
a=10.4321(12)Å b=8.1179(11)Å c=14.791(2)Å
α=90.00° β=109.633(6)° γ=90.00°
4-[2-(4-aminophenylsulfamyl)ethyl]phenol
C14H15NOS
Journal of the American Chemical Society (2003) 125, 14495-14509
a=12.6341(9)Å b=5.8636(4)Å c=8.5671(5)Å
α=90.00° β=90.351(3)° γ=90.00°
4-[(E)-2-(4-aminophenyl)-1-ethenyl]phenol
C14H13NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=12.951(8)Å b=5.226(3)Å c=8.046(3)Å
α=90.00° β=98.12(3)° γ=90.00°
4-(4-aminophenoxy)phenol
C12H11NO2
Journal of the American Chemical Society (2003) 125, 14495-14509
a=22.4911(11)Å b=5.4647(2)Å c=8.0466(4)Å
α=90.00° β=95.674(2)° γ=90.00°
4-[5-(4-aminophenyl)pentyl]phenol
C17H21NO
Journal of the American Chemical Society (2003) 125, 14495-14509
a=14.9554(9)Å b=11.2370(8)Å c=8.6841(6)Å
α=90.00° β=90.893(3)° γ=90.00°
4-(4-aminophenylsulfamyl)phenol
C12H11NOS
Journal of the American Chemical Society (2003) 125, 14495-14509
a=9.8597(3)Å b=10.0879(3)Å c=21.8081(7)Å
α=90.00° β=102.8090(10)° γ=90.00°
1,3-bis(3-pyridyl)ureahydrate(3:4)
C11H10N40,4/3(H2O)
Crystal Growth & Design (2006) 6, 1 161
a=12.941(3)Å b=11.789(2)Å c=22.401(5)Å
α=90.00° β=101.37(3)° γ=90.00°
N,N'-bis(3-pyridyl)urea+succinicacid
C11H11N4O,C4H5O4
Crystal Growth & Design (2006) 6, 1 161
a=38.093(8)Å b=5.2820(11)Å c=16.428(3)Å
α=90.00° β=109.35(3)° γ=90.00°
N-(3-pyridyl)-N'-phenylurea
C12H11N3O
Crystal Growth & Design (2006) 6, 1 161
a=11.7789(13)Å b=9.4606(10)Å c=18.262(2)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(3-pyridyl)urea+Fumaricacid+water
C11H11N4O,C4H3O4,H2O
Crystal Growth & Design (2006) 6, 1 161
a=7.404(2)Å b=8.068(4)Å c=13.562(3)Å
α=104.55(3)° β=98.02(2)° γ=95.52(3)°
1,3-bis(3-N-methylpyridinium)urea diiodide
C13H16N4O,2(I)
Crystal Growth & Design (2006) 6, 1 161
a=7.7439(15)Å b=10.464(2)Å c=10.683(2)Å
α=101.42(3)° β=100.55(3)° γ=99.28(3)°
1,3-bis(3-pyridyl)urea
C11H10N4O
Crystal Growth & Design (2006) 6, 1 161
a=13.707(3)Å b=7.0140(14)Å c=10.006(2)Å
α=90.00° β=90.00° γ=90.00°
1,3-bis(3-pyridyl)urea dihydrate
C11H10N4O,2(H2O)
Crystal Growth & Design (2006) 6, 1 161
a=6.8138(5)Å b=19.586(11)Å c=9.292(4)Å
α=90.00° β=101.24(3)° γ=90.00°
N,N'-bis(3-pyridyl-N-oxide)urea dihydrate
C11H10N4O3,H2O
Crystal Growth & Design (2006) 6, 1 161
a=7.9686(7)Å b=12.2243(11)Å c=24.538(2)Å
α=90.00° β=90.650(2)° γ=90.00°
3-[(E)-2-(4-aminophenyl)-1-ethenyl]phenol
C14H13NO
Crystal Growth & Design (2004) 4, 4 647
a=11.4815(5)Å b=26.0534(16)Å c=7.1885(4)Å
α=90.00° β=90.00° γ=90.00°
3-(4-aminophenethyl)phenol
C14H15NO
Crystal Growth & Design (2004) 4, 4 647
a=7.6679(2)Å b=26.1975(6)Å c=11.1698(2)Å
α=90.00° β=90.00° γ=90.00°
1:1 Cocrystal of nitrofurantoin and 3-aminobenzoic acid
C8H6N4O5,C7H7NO2
Crystal Growth & Design (2012) 12, 12 5925
a=9.1485(18)Å b=9.4656(19)Å c=9.903(2)Å
α=107.39(3)° β=98.66(3)° γ=97.17(3)°
1:1 Cocrystal of nitrofurantoin and 4-aminobenzoic acid
C8H6N4O5,C7H7NO2
Crystal Growth & Design (2012) 12, 12 5925
a=6.7539(14)Å b=7.4546(15)Å c=16.032(3)Å
α=92.64(3)° β=91.81(3)° γ=102.47(3)°
C27H15F3O6
C27H15F3O6
Crystal Growth & Design (2010) 10, 1 224
a=19.872(2)Å b=3.8652(5)Å c=28.764(3)Å
α=90.00° β=90.584(5)° γ=90.00°
C27H15Br3O6
C27H15Br3O6
Crystal Growth & Design (2010) 10, 1 224
a=3.8321(5)Å b=27.975(3)Å c=23.031(3)Å
α=90.00° β=90.108(6)° γ=90.00°
C27H15Br3O3
C27H15Br3O3
Crystal Growth & Design (2010) 10, 1 224
a=11.6382(13)Å b=14.1355(15)Å c=14.9051(16)Å
α=90.00° β=109.070(5)° γ=90.00°
(C27H15O6Br3),(CH2Cl2)0.43,(CH4O)0.26
(C27H15O6Br3),(CH2Cl2)0.43,(CH4O)0.26
Crystal Growth & Design (2010) 10, 1 224
a=46.434(5)Å b=3.9139(5)Å c=34.656(4)Å
α=90.00° β=120.273(5)° γ=90.00°
2(C27H15I3O6),CH2Cl2
2(C27H15I3O6),CH2Cl2
Crystal Growth & Design (2010) 10, 1 224
a=4.2535(3)Å b=41.981(3)Å c=15.1423(12)Å
α=90.00° β=97.928(4)° γ=90.00°
C27H15I3O3
C27H15I3O3
Crystal Growth & Design (2010) 10, 1 224
a=11.9616(13)Å b=14.2501(15)Å c=14.9466(16)Å
α=90.00° β=106.816(5)° γ=90.00°
(C27H15O6Cl3),(CH2Cl2)0.336,(CH6O)0.090
(C27H15O6Cl3),(CH2Cl2)0.336,(CH6O)0.090
Crystal Growth & Design (2010) 10, 1 224
a=3.8968(5)Å b=21.877(3)Å c=29.152(3)Å
α=90.00° β=91.083(5)° γ=90.00°
(4-(4-hydroxybenzyl)phenol).(4-(4-aminobenzyl)aniline)
C26H26N2O2
Crystal Growth & Design (2005) 5, 1 99
a=11.401(4)Å b=9.943(3)Å c=19.681(6)Å
α=90.00° β=103.500(10)° γ=90.00°
(4-(4-aminobenzyl)aniline).(4-(4-hydroxyphenylsulfanyl)phenol)
C25H24N2O2S
Crystal Growth & Design (2005) 5, 1 99
a=11.2547(11)Å b=10.1129(9)Å c=19.9982(17)Å
α=90.00° β=103.654(5)° γ=90.00°
(4-(4-hydroxybenzyl)phenol).(4-(4-aminophenylsulfanyl)aniline)
C25H24N2O2S
Crystal Growth & Design (2005) 5, 1 99
a=5.25280(10)Å b=42.3571(6)Å c=9.42140(10)Å
α=90.00° β=94.8010(10)° γ=90.00°
(4-(4-aminophenylsulfanyl)aniline).(4-(4-hydroxyphenylsulfanyl)phenol)
C24H22N2O2S2
Crystal Growth & Design (2005) 5, 1 99
a=9.9090(4)Å b=10.2700(4)Å c=22.0100(8)Å
α=90.00° β=90.00° γ=90.00°
1:1 cocrystal of nitrofurantoin and urea
C8H6N4O5,CH4N2O
Crystal Growth & Design (2012) 12, 12 5925
a=6.6779(13)Å b=13.648(3)Å c=14.003(4)Å
α=90.00° β=110.95(3)° γ=90.00°
1:2 Cocrystal of nitrofurantoin and 4-hydroxybenzamide
C8H6N4O5,C7H7NO2,C7H7NO2
Crystal Growth & Design (2012) 12, 12 5925
a=6.810(2)Å b=15.644(5)Å c=21.120(7)Å
α=90.00° β=93.260(7)° γ=90.00°
1:1 Cocrystal of nitrofurantoin and phenazine (two half molecules)
C20H14N6O5
Crystal Growth & Design (2012) 12, 12 5925
a=8.7234(17)Å b=9.969(2)Å c=11.547(2)Å
α=65.43(3)° β=86.27(3)° γ=84.23(3)°
1:1:1 Cocrystal of nitrofurantoin, melamine and water
C8H6N4O5,C3H6N6,H2O
Crystal Growth & Design (2012) 12, 12 5925
a=6.8748(14)Å b=10.541(2)Å c=11.088(2)Å
α=75.64(3)° β=82.27(3)° γ=84.85(3)°
1:1/2:1 Cocrystal of nitrofurantoin, 4,4'-bipyridyl and water
C13H12N5O6
Crystal Growth & Design (2012) 12, 12 5925
a=31.804(6)Å b=6.7822(14)Å c=13.672(3)Å
α=90.00° β=99.86(3)° γ=90.00°
1:1:1 Cocrystal of nitrofurantoin, 4,4'-bipyridyl ethane and water
C28H28N10O12
Crystal Growth & Design (2012) 12, 12 5925
a=6.4093(13)Å b=13.597(3)Å c=19.138(4)Å
α=106.54(3)° β=93.68(3)° γ=100.76(3)°
C38H41Cl2NO17S
C38H41Cl2NO17S
Crystal Growth & Design (2012) 12, 12 5858
a=8.7080(17)Å b=19.666(4)Å c=11.532(2)Å
α=90.00° β=96.70(3)° γ=90.00°
1,3-bis(3-pyridyl)ureadihydrate
C11H10N4O,2(H2O)
Crystal Growth & Design (2006) 6, 1 161
a=6.7932(8)Å b=19.560(2)Å c=9.2746(11)Å
α=90.00° β=101.260(2)° γ=90.00°